X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ACTA PHARMACEUTICA

期刊標題檢索 ACTA PHARMACEUT 最新評論: That's just okay, as long as I can graduate. My senior published a pa... (2017-07-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ACTA PHARMACEUTICA]您好,您是該頁面的第 30836 位訪客。

期刊簡介
期刊名稱ACTA PHARMACEUTICA ACTA PHARMACEUTICA
LetPub Score
4.9
50 ratings
Rate

Reputation
5.9

Influence
3.7

Speed
7.0

期刊簡稱ACTA PHARMACEUT
ISSN1330-0075
E-ISSN1846-9558
h-index49
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.200.4130.653
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q266 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q2145 / 313

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.

AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.


To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.

AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.


Topics covered are:
• drug design

• molecular modelling/docking studies

• pharmaceutical chemistry/medicinal chemistry

• drug metabolism

• analytics of drugs

• pharmaceutical technology/formulation studies/nanosystems/cosmetology

• pharmaceutical biotechnology

• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics

• drug delivery/disposition and stability

• pharmacognosy and phytopharmacy

• pharmacology (clinical and animal)

• toxicology

• clinical pharmacy

• pharmacovigilance

• pharmaceutical and clinical biochemistry

• pharmaceutical biology with genetics/pharmacogenomics/cell biology

• pharmacoepidemiology/pharmacoeconomics/social pharmacy

• physical pharmacy

• radiopharmaceuticals

• medicine (including diagnostics and therapy)

• peptide and protein chemistry/protein design
官方網站https://sciendo.com/journal/ACPH
在線稿件提交Submit By Email: acta.pharmaceutica@farmaceut.org or svjetlana.luterotti@gmail.com or svjetlana.luterotti@pharma.hr
開放訪問Yes
出版商Sciendo, a De Gruyter company
主題領域PHARMACOLOGY & PHARMACY
出版國/地區CROATIA
發行頻率四半期刊行
創刊年1951
每年文章數45每年文章數趨勢
黃金OA百分比98.44%
OA Related Info
APC: Yes( EUR900; )
APC waiver:No
Other charges: No
Keywords: biomedicine、pharmaceutical and related sciences
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3210/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1330-0075%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【ACTA PHARMACEUTICA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645713
    BIOMATERIALS601306
    Frontiers in Pharmacology503480
    BIOMEDICINE & PHARMACOTHERAPY498660
    JOURNAL OF ETHNOPHARMACOLOGY495875
    Journal of Materials Chemistry B476181
    Frontiers in Immunology461419
    COMPUTERS IN BIOLOGY AND MEDICINE420611
    COLLOIDS AND SURFACES B-BIOINTERFACES419543
    Frontiers in Oncology415879
  •  

    ACTA PHARMACEUTICA ACTA PHARMACEUTICA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ACTA PHARMACEUTICA] 的評論撰寫評論
作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 11:31:00 評論於
That's just okay, as long as I can graduate. My senior published a paper last year, so I consider it a successful graduation. Good luck with everything
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ACTA PHARMACEUTICA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*